Migraine Clinical Trial
Official title:
Outcomes of Following Surgical Decompression for the Treatment of Migraine
NCT number | NCT04008303 |
Other study ID # | 190993 |
Secondary ID | |
Status | Withdrawn |
Phase | |
First received | |
Last updated | |
Start date | May 2020 |
Est. completion date | June 1, 2020 |
Verified date | January 2021 |
Source | Vanderbilt University Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Migraines are very common and affect over 35 million Americans a year. Migraines can be painful and affect daily life. The cause of migraine is multifactorial and not completely understood. Treatment usually includes different classes of medications, life style changes, physical therapy, acupuncture, nerve stimulators and avoiding common triggers (like bright lights, certain foods, or loud sounds). For some patients, Botox injected into the muscles of the forehead and neck can significantly reduce pain. Unfortunately, this does not provide long-term relief as the effect of Botox lasts for 3 months. Since year 2000 surgery to treat a selected population of migraine patients has been gaining popularity and showing promising results. The surgery reduces the pressure on the peripheral nerves that are believed to cause migraine headaches by resecting the surrounding tissue (bone, fascia, muscle, and arteries). This surgery provides a more long-term and permanent relief. The purpose of this study is to follow the effectiveness and outcomes of migraine surgery.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | June 1, 2020 |
Est. primary completion date | June 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - 18 years or older - Cleared by neurology and headache specialists for surgery - Patient cleared by neurology for not having medication overuse headaches - Patient able to localize a consistent trigger site where the migraines start - Patient has been suffering from migraine for more than 2 years - Botox injections or nerve blocks have worked for migraine relief in the past - Patients formally diagnosed with migraine headaches by a neurologist - Migraines impact quality of life per MIDAS survey - No history of Mania, Bipolar disorder, Major Dispersive disorder, or suicidal ideation Exclusion Criteria: - High dose opioid medication use - Does not meet criteria for migraine diagnosis - History of prior surgery for migraines |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Vanderbilt University Medical Center |
Gfrerer L, Guyuron B. Surgical treatment of migraine headaches. Acta Neurol Belg. 2017 Mar;117(1):27-32. doi: 10.1007/s13760-016-0731-1. Epub 2016 Dec 24. Review. — View Citation
Guyuron B, Kriegler JS, Davis J, Amini SB. Comprehensive surgical treatment of migraine headaches. Plast Reconstr Surg. 2005 Jan;115(1):1-9. — View Citation
Guyuron B, Kriegler JS, Davis J, Amini SB. Five-year outcome of surgical treatment of migraine headaches. Plast Reconstr Surg. 2011 Feb;127(2):603-8. doi: 10.1097/PRS.0b013e3181fed456. — View Citation
Guyuron B, Reed D, Kriegler JS, Davis J, Pashmini N, Amini S. A placebo-controlled surgical trial of the treatment of migraine headaches. Plast Reconstr Surg. 2009 Aug;124(2):461-8. doi: 10.1097/PRS.0b013e3181adcf6a. — View Citation
Guyuron B, Varghai A, Michelow BJ, Thomas T, Davis J. Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg. 2000 Aug;106(2):429-34; discussion 435-7. — View Citation
Janis JE, Barker JC, Javadi C, Ducic I, Hagan R, Guyuron B. A review of current evidence in the surgical treatment of migraine headaches. Plast Reconstr Surg. 2014 Oct;134(4 Suppl 2):131S-41S. doi: 10.1097/PRS.0000000000000661. — View Citation
Lee M, Monson MA, Liu MT, Reed D, Guyuron B. Positive botulinum toxin type a response is a prognosticator for migraine surgery success. Plast Reconstr Surg. 2013 Apr;131(4):751-7. doi: 10.1097/PRS.0b013e3182818b7f. — View Citation
Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain. 2005 Dec;6(6):429-40. Epub 2005 Dec 15. Review. — View Citation
Negro A, Rocchietti-March M, Fiorillo M, Martelletti P. Chronic migraine: current concepts and ongoing treatments. Eur Rev Med Pharmacol Sci. 2011 Dec;15(12):1401-20. Review. — View Citation
Stewart WF, Simon D, Shechter A, Lipton RB. Population variation in migraine prevalence: a meta-analysis. J Clin Epidemiol. 1995 Feb;48(2):269-80. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in International Classification of Headache Disorders Diagnostic criteria: Frequency | Frequency
Number of migraine headaches per day Number of migraine headaches per week |
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative | |
Primary | Change in International Classification of Headache Disorders Diagnostic criteria: Duration | Duration
-How long the migraine headaches last in minutes |
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative | |
Primary | Change in International Classification of Headache Disorders Diagnostic criteria: Location | Location
Area of head that hurts with migraines. Options include front, side, top, and back. |
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative | |
Primary | Change in International Classification of Headache Disorders Diagnostic criteria: Quality | Quality
Description of the migraine pain. Options include sharp, stabbing, dull, pulsating, and burning. |
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative | |
Primary | Change in International Classification of Headache Disorders Diagnostic criteria: Severity | Severity
- Migraine headache severity graded on a 0-10 scale, with 10 being the most severe. |
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative | |
Primary | Change in International Classification of Headache Disorders Diagnostic criteria: Laterality | Laterality
Side of the head that is impacted with migraine headaches Options include right, left, or both. |
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative | |
Primary | Change in International Classification of Headache Disorders Diagnostic criteria: Associated Symptoms | Associated symptoms
Question to record associated symptoms that occur with migraine headaches Options include nausea, vomiting, photophobia, photophobia, and aura symptoms |
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative | |
Primary | Change in International Classification of Headache Disorders Diagnostic criteria: Exacerbating factors | Exacerbating factors
Open ended question to record anything that makes the migraine headaches worse. Examples include medications, environmental triggers (light, noise, etc), and lifestyle (stress, exercise, etc) |
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative | |
Primary | Change in International Classification of Headache Disorders Diagnostic criteria: Relieving factors | Relieving factors
Open ended question to record anything that makes the migraine headaches better. Examples include medications, avoidance of environmental triggers (light, noise, etc), and lifestyle changes (stress avoidance, exercise, etc) |
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06192173 -
Patent Foramen Ovale Closure in Migraine
|
||
Completed |
NCT05525611 -
Cabergoline as a Preventive Treatment for Chronic Migraine
|
N/A | |
Recruiting |
NCT03832998 -
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
|
Phase 3 | |
Enrolling by invitation |
NCT04196933 -
Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
|
N/A | |
Not yet recruiting |
NCT06428838 -
Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context
|
Phase 3 | |
Completed |
NCT06304675 -
Manageable Environmental Factors in Migraine
|
||
Completed |
NCT04084314 -
Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study
|
Phase 4 | |
Recruiting |
NCT05517200 -
Pilot Study for a Machine Learning Test for Migraine
|
||
Completed |
NCT04179474 -
Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine
|
Phase 1 | |
Recruiting |
NCT04603976 -
Registry for Migraine - Clinical Core
|
Phase 4 | |
Completed |
NCT03597529 -
CHOCOlate MeLatonin for AdolescenT MigrainE
|
Phase 2 | |
Completed |
NCT04197349 -
Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman
|
Phase 1 | |
Recruiting |
NCT05891808 -
miR-155 Expression in Episodic and Chronic Migraine
|
||
Active, not recruiting |
NCT05064371 -
Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan
|
Phase 3 | |
Suspended |
NCT04069572 -
Vibratory Stimulation for the Treatment of Chronic Pain
|
N/A | |
Not yet recruiting |
NCT04859374 -
Chronic Pain and Conditioned Pain Modulation After on Line-behavioral Approach
|
N/A | |
Not yet recruiting |
NCT03083860 -
Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.
|
N/A | |
Completed |
NCT02905227 -
A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder
|
Phase 1 | |
Enrolling by invitation |
NCT02532023 -
The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients
|
Phase 4 | |
Completed |
NCT02108678 -
One-Day Intervention for Depression and Impairment in Migraine Patients
|
N/A |